Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China

Figures & data

Figure 1. Patient flowchart.

Figure 2. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) by age and sex.

Table 1. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) by age and sex.

Age (years)	Men, % (n, 95% CI)	Women, % (n, 95% CI)	Total, % (n, 95% CI)
<30	0.08 (2/2402, 0.02–0.33)	0.14 (3/2119, 0.04–0.45)	0.11 (5/4521, 0.04–0.27)
31–40	0.39 (27/6967, 0.27–0.57)	0.28 (15/5424, 0.16–0.47)	0.34 (42/12,391, 0.25–0.46)
41–50	0.99 (86/8645, 0.80–1.23)	0.96 (67/7004, 0.75–1.22)	0.98 (153/15,649, 0.83–1.15)
51–60	2.17 (129/5935, 1.83–2.58)	1.56 (87/5573, 1.26–1.93)	1.88 (216/11,508, 1.64–2.15)
61–70	3.15 (66/2092, 2.46–4.02)	2.12 (45/2121, 1.57–2.85)	2.63 (111/4213, 2.18–3.17)
71–80	7.43 (30/404, 5.15–10.55)	2.81 (11/392, 1.49–5.12)	5.15 (41/796, 3.76–6.98)
≥80	7.50 (6/80, 3.09–16.20)	3.23 (2/62, 0.56–12.18)	6.67 (8/142, 2.64–11.16)
<50	0.64 (115/18014, 0.53–0.77)	0.58 (85/14,547, 0.47–0.72)	0.61 (200/32,561, 0.53–0.70)
≥50	2.71 (231/8511, 2.38–3.08)	1.78 (145/8148, 1.51–2.10)	2.26 (376/16,659, 2.04–2.50)
Total	1.35 (357/26525, 1.22–1.50)	0.96 (219/22,695, 0.84–1.10)	1.17 (576/49,220, 1.08–1.27)

Figure 3. Characteristics of patients with monoclonal gammopathy of undetermined significance.

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.